257 related articles for article (PubMed ID: 28675046)
1. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
Kurtul A
Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
[TBL] [Abstract][Full Text] [Related]
2. CHA
Zhao SG; Xu JJ; Tao ZH; Jin L; Liu Q; Zheng WY; Jiang LQ; Wang NF
J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Predictive Value of CHA
Yilmaz S; Akboga MK; Aras D; Topaloglu S
Angiology; 2018 Jan; 69(1):38-42. PubMed ID: 28345395
[TBL] [Abstract][Full Text] [Related]
4. Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent.
Celik IE; Yarlioglues M; Kurtul A; Duran M; Koseoglu C; Oksuz F; Aksoy O; Murat SN
Angiology; 2016 May; 67(5):478-83. PubMed ID: 26243483
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
Almalla M; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
[TBL] [Abstract][Full Text] [Related]
7. The Predictive Value of the CHA2DS2-VASc Score for In-Stent Restenosis Among Patients with Drug-Eluting Stents Implantation.
Zhao J; Hou L; Zhu N; Huang R; Su K; Lei Y; Li Y
Int J Gen Med; 2023; 16():69-76. PubMed ID: 36636712
[TBL] [Abstract][Full Text] [Related]
8. Coronary CT angiography (CCTA) using third-generation dual-source CT for ruling out in-stent restenosis.
Eckert J; Renczes-Janetzko P; Schmidt M; Magedanz A; Voigtländer T; Schmermund A
Clin Res Cardiol; 2019 Apr; 108(4):402-410. PubMed ID: 30187179
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S
Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
[TBL] [Abstract][Full Text] [Related]
10. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.
Turak O; Ozcan F; Isleyen A; Tok D; Sokmen E; Buyukkaya E; Aydogdu S; Akpek M; Kaya MG
Am J Cardiol; 2012 Nov; 110(10):1405-10. PubMed ID: 22858185
[TBL] [Abstract][Full Text] [Related]
12. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease.
Murat SN; Yarlioglues M; Celik IE; Kurtul A; Duran M; Kilic A; Oksuz F
Clin Appl Thromb Hemost; 2017 Apr; 23(3):235-240. PubMed ID: 26759373
[TBL] [Abstract][Full Text] [Related]
15. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
16. Importance and usage of the CHA2DS2-VASc score in predicting acute stent thrombosis.
Ünal S; Açar B; Yayla Ç; Balci MM; Ertem A; Kara M; Maden O; Dereağzi ŞF
Coron Artery Dis; 2016 Sep; 27(6):478-82. PubMed ID: 27187546
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
18. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
[TBL] [Abstract][Full Text] [Related]
19. Value of CHA2DS2-VASc Score for Prediction and Ruling Out of Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention.
Açikgöz SK; Açikgöz E; Çiçek G
Angiology; 2020 May; 71(5):411-416. PubMed ID: 32030991
[TBL] [Abstract][Full Text] [Related]
20. Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry.
Gondo K; Ike A; Ogawa M; Shirai K; Sugihara M; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Miura S; Yasunaga S; Saku K
J Cardiol; 2017 Apr; 69(4):652-659. PubMed ID: 27492658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
